Herceptin plus chemotherapy combination in preoperative regimen may offer clinical benefit in early stage breast cancer

Nuhad Ibrahim, Deborah Francis, Daniel Booser, Eva Thomas, Richard Theriault, Lajos Pusztai, Marjorie Green, Banu Arun, Sharon Giordano, Massimo Cristofanilli, Debra Frye, Terry Smith, Kelly Hunt, Eva Singletary, Aysegul Sahin, Michael Ewer, Thomas Buchholz, Donald Berry, Gabriel Hortobagyi

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
JournalCancer Biology and Therapy
Volume4
Issue number5
StatePublished - May 1 2005

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Ibrahim, N., Francis, D., Booser, D., Thomas, E., Theriault, R., Pusztai, L., Green, M., Arun, B., Giordano, S., Cristofanilli, M., Frye, D., Smith, T., Hunt, K., Singletary, E., Sahin, A., Ewer, M., Buchholz, T., Berry, D., & Hortobagyi, G. (2005). Herceptin plus chemotherapy combination in preoperative regimen may offer clinical benefit in early stage breast cancer. Cancer Biology and Therapy, 4(5).